Gregory A Gould - Net Worth and Insider Trading

Gregory A Gould Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory A Gould owns 5 companies in total, including NewAge Inc (NBEVQ) , CytoDyn Inc (CYDY) , and Aytu BioPharma Inc (AYTU) among others .

Click here to see the complete history of Gregory A Gould’s form 4 insider trades.

Insider Ownership Summary of Gregory A Gould

Ticker	Comapny	Transaction Date	Type of Owner
NBEVQ	NewAge Inc	2019-07-01	CFO
CYDY	CytoDyn Inc	2013-05-31	director
AYTU	Aytu BioPharma Inc	2015-04-16	Chief Financial Officer
		2014-06-10	Chief Financial Officer
		2005-04-20	Sr VP and CFO

Gregory A Gould Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregory A Gould Ownership Network

Ownership Network List of Gregory A Gould

No Data

Ownership Network Relation of Gregory A Gould

Gregory A Gould Owned Company Details

What does NewAge Inc do?

Who are the key executives at NewAge Inc?

Gregory A Gould is the CFO of NewAge Inc. Other key executives at NewAge Inc include Chief Financial Officer Kevin Manion , Chief Operating Officer David Vanderveen , and Chief Marketing Officer Julie Garlikov .

NewAge Inc (NBEVQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NewAge Inc (NBEVQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NewAge Inc (NBEVQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NewAge Inc (NBEVQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

NewAge Inc Insider Transactions

No Available Data

What does CytoDyn Inc do?

Who are the key executives at CytoDyn Inc?

Gregory A Gould is the director of CytoDyn Inc. Other key executives at CytoDyn Inc include EVP of Legal Affairs Tyler Blok , President Arvin Cyrus Arman , and Chief Financial Officer Antonio Migliarese .

CytoDyn Inc (CYDY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoDyn Inc (CYDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoDyn Inc (CYDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoDyn Inc (CYDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

CytoDyn Inc Insider Transactions

No Available Data

What does Aytu BioPharma Inc do?

Who are the key executives at Aytu BioPharma Inc?

Gregory A Gould is the Chief Financial Officer of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .

Aytu BioPharma Inc (AYTU) Insider Trades Summary

Over the past 18 months, Gregory A Gould made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 126,371 shares made by Joshua R. Disbrow , and a net purchase of 100,000 shares made by Greg Pyszczymuka .

In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 24,619 shares were bought by its insiders, resulting in a net purchase of 24,619 shares.

Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aytu BioPharma Inc Insider Transactions

No Available Data

What does Ampio Pharmaceuticals Inc do?

Who are the key executives at Ampio Pharmaceuticals Inc?

Gregory A Gould is the Chief Financial Officer of Ampio Pharmaceuticals Inc. Other key executives at Ampio Pharmaceuticals Inc include Chief Operating Officer Holli Cherevka , CFO Dan Stokely , and Chief Financial Officer Chilcott, Iii Thomas E. .

Ampio Pharmaceuticals Inc (AMPE) Insider Trades Summary

Over the past 18 months, Gregory A Gould made no insider transaction in Ampio Pharmaceuticals Inc (AMPE). Other recent insider transactions involving Ampio Pharmaceuticals Inc (AMPE) include a net purchase of 146,858 shares made by J Kevin Buchi , a net purchase of 95,000 shares made by David R Stevens , and a net purchase of 76,890 shares made by Michael A Martino .

In summary, during the past 3 months, insiders sold 0 shares of Ampio Pharmaceuticals Inc (AMPE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ampio Pharmaceuticals Inc (AMPE) were sold and 15,937 shares were bought by its insiders, resulting in a net purchase of 15,937 shares.

Ampio Pharmaceuticals Inc (AMPE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ampio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Integrated Biopharma Inc do?

Who are the key executives at Integrated Biopharma Inc?

Gregory A Gould is the Sr VP and CFO of Integrated Biopharma Inc. Other key executives at Integrated Biopharma Inc include director & 10 percent owner William H. Milmoe , director & 10 percent owner & Chairman and CEO E Gerald Kay , and director & President and CEO Jeffrey R Leach .

Integrated Biopharma Inc (INBP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Integrated Biopharma Inc (INBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Integrated Biopharma Inc (INBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Integrated Biopharma Inc (INBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Integrated Biopharma Inc Insider Transactions

No Available Data

Gregory A Gould Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory A Gould. You might contact Gregory A Gould via mailing address: 1111 Main Street, Suite 660, Vancouver Wa 98660.

Discussions on Gregory A Gould

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.